Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovoCure

18.50
-0.0500-0.27%
Post-market: 18.750.2500+1.35%18:03 EDT
Volume:1.01M
Turnover:18.75M
Market Cap:2.06B
PE:-12.24
High:18.97
Open:18.25
Low:17.96
Close:18.55
Loading ...

Analysts Are Bullish on Top Healthcare Stocks: NovoCure (NVCR), Altimmune (ALT)

TIPRANKS
·
28 Feb

Novocure Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

NovoCure (NVCR) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
·
27 Feb

Stock Track | NovoCure Stock Plummets 8.38% in Pre-Market as Wider Q4 Loss Offsets Revenue Growth

Stock Track
·
27 Feb

Stock Track | NovoCure Plunges 6.4% in Pre-Market Trading as Q4 Loss Widens on Higher Expenses

Stock Track
·
27 Feb

NovoCure's Q4 Loss Widens, Revenue Rises

MT Newswires Live
·
27 Feb

NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
27 Feb

NovoCure Q4 EPS Misses, Revenue Matches

Motley Fool
·
27 Feb

NovoCure: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

NovoCure Q4 2024 GAAP EPS $(0.61) Misses $(0.34) Estimate, Sales $161.27M Beat $157.81M Estimate

Benzinga
·
27 Feb

BRIEF-Novocure Q4 Revenue USD 161.266 Million Vs. IBES Estimate USD 157.8 Million

Reuters
·
27 Feb

Novocure Ltd - Actively Working to Mitigate Any Potential Impacts From Tariffs in Medium-to-Long Term

THOMSON REUTERS
·
27 Feb

Novocure Ltd - Should Not Be a Material Impact to Margins in Short Term From Tariffs

THOMSON REUTERS
·
27 Feb

Novocure Q4 Gross Profit USD 127.8 Million

THOMSON REUTERS
·
27 Feb

Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?

Simply Wall St.
·
12 Feb

Jim Cramer on NovoCure Limited (NVCR): ‘I Have Watched Them For Years And Years And They’re Not Making Money’

Insider Monkey
·
31 Jan

NovoCure Opens New Global Headquarters in Switzerland

MT Newswires Live
·
22 Jan

Novocure opens new global headquarters in Switzerland

TIPRANKS
·
22 Jan

Investing in NovoCure (NASDAQ:NVCR) a year ago would have delivered you a 85% gain

Simply Wall St.
·
21 Jan

Novocure Price Target Maintained With a $38.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan